Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial
NCT02904642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 537
Last updated 2018-03-01
Summary
The overall objective is to test the impact of short message service (SMS) reminders, with or without unconditionally provided mobile-money incentives, can improve measles vaccination coverage in rural western Kenyan infants.
Conditions
Interventions
- BEHAVIORAL
-
SMS reminder
Caregivers will receive two text message reminders for their child's measles immunization scheduled for 9 months of age
- BEHAVIORAL
-
Unconditional Incentive
A mobile-money incentive in the amount of 150 Kenyan Shillings will be transferred to the enrolled caregiver's mobile phone when the child reaches nine months of age
Sponsors & Collaborators
-
Kenya Medical Research Institute
collaborator OTHER -
Bill and Melinda Gates Foundation
collaborator OTHER -
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-12-06
- Primary Completion
- 2017-04-04
- Completion
- 2017-04-04
More Related Trials
-
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda
NCT04177485 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices
NCT01557699 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
NCT01668745 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of ShotBlocker on Pain and Satisfaction During Measles-Rubella-Mumps Vaccination
NCT06762938 ·Status: COMPLETED ·Phase: NA
-
Impact of HIV on Measles and Measles Immunisation
NCT00247091 ·Status: COMPLETED
-
Non-Specific Effects of Standard Titre Measles Vaccination
NCT00168662 ·Status: COMPLETED ·Phase: PHASE4
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
Measles Vaccine in HCW
NCT04357028 ·Status: SUSPENDED ·Phase: PHASE3
-
mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (D0271)
NCT03252288 ·Status: COMPLETED ·Phase: NA
-
Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children
NCT03460002 ·Status: COMPLETED ·Phase: PHASE4
-
Measles Vaccination Cash Incentives Experimental Evidence From Nigeria
NCT04013516 ·Status: COMPLETED ·Phase: NA
-
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT06470919 ·Status: COMPLETED ·Phase: NA
-
Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
NCT05803538 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Antibiotics in Measles
NCT00168532 ·Status: COMPLETED ·Phase: PHASE3
-
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
NCT05758532 ·Status: RECRUITING ·Phase: PHASE4
-
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan
NCT03341195 ·Status: UNKNOWN ·Phase: NA
-
SMS Reminders to Improve the on Time Vaccination Rates Among Children in Pakistan
NCT01859546 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
NCT06062238 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Additional Measles Vaccine at 4 Months of Age
NCT01486355 ·Status: UNKNOWN ·Phase: PHASE4
-
Measles, Mumps, and Rubella (MMR) Immunity in College Students
NCT00962819 ·Status: COMPLETED
-
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
NCT01830257 ·Status: UNKNOWN ·Phase: PHASE4
-
The Interaction Between Measles and DTP Vaccination
NCT02710045 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
NCT00427830 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
NCT00891007 ·Status: COMPLETED ·Phase: PHASE2
-
Early Two-dose Measles Vaccination Trial
NCT00168558 ·Status: COMPLETED ·Phase: PHASE4